Evaluation of Sequencing of Anthracyclines and Taxanes for Locally Advanced HER2-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel or Paclitaxel|DRUG: Cyclophosphamide + Doxorrubicin
Sponsor: Latin American Cooperative Oncology Group